<DOC>
	<DOC>NCT01224899</DOC>
	<brief_summary>The investigators sought to evaluate the feasibility and safety of surgical sympathetic blockade in systolic heart failure patients and secondary to assess its cardiovascular consequences.</brief_summary>
	<brief_title>Surgical Sympathetic Blockade in Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure, Systolic</mesh_term>
	<criteria>chronic heart failure (at least 1 month of symptoms onset) NYHA functional class II or III LV ejection fraction 40% or lower resting heart rate higher than 65 bpm either maximum betablocker therapy according to guidelines or no betablocker use for intolerance. NYHA functional class I or IV cardiogenic shock resting heart rate â‰¤ 65 bpm systolic blood pressure &lt; 90 mmHg sustained ventricular tachycardia eligibility to other surgical procedures procedurelimiting comorbidity presence of ICD or pacemaker valvar, chagasic or congenital cardiomyopathy age &gt; 70 years patient refusal contraindication to videothoracoscopy decompensated thyroid disease atrial fibrillation or flutter active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Sympathetic Nervous System</keyword>
	<keyword>Sympathectomy</keyword>
	<keyword>Adrenergic beta-Antagonists</keyword>
	<keyword>Ventricular Dysfunction, Left</keyword>
</DOC>